Literature DB >> 15727870

Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors.

Sheng Biao Wan1, Kristin R Landis-Piwowar, Deborah J Kuhn, Di Chen, Q Ping Dou, Tak Hang Chan.   

Abstract

The structure-activity relationship of a number of synthetic green tea polyphenol analogs involving modifications of A ring and B ring of epi-gallocatechin gallate (EGCG) as proteasome inhibitors has been examined. It was found that in B ring, a decrease in the number of OH groups led to decreased potency. Introduction of a hydrophobic benzyl group into the 8 position of A ring did not significantly affect the proteasome-inhibitory potency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727870     DOI: 10.1016/j.bmc.2004.12.056

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

2.  Synthesis and structure-activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor.

Authors:  Anuj Khandelwal; Jessica A Hall; Brian S J Blagg
Journal:  J Org Chem       Date:  2013-08-01       Impact factor: 4.354

3.  Anti-staphylococcal activity and β-lactam resistance attenuating capacity of structural analogues of (-)-epicatechin gallate.

Authors:  James C Anderson; Robert A McCarthy; Sarah Paulin; Peter W Taylor
Journal:  Bioorg Med Chem Lett       Date:  2011-10-08       Impact factor: 2.823

Review 4.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 5.  EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

Authors:  Di Chen; Sheng Biao Wan; Huanjie Yang; Jian Yuan; Tak Hang Chan; Q Ping Dou
Journal:  Adv Clin Chem       Date:  2011       Impact factor: 5.394

Review 6.  Green tea polyphenols as proteasome inhibitors: implication in chemoprevention.

Authors:  H Yang; K Landis-Piwowar; T H Chan; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

Review 7.  The challenge of developing green tea polyphenols as therapeutic agents.

Authors:  C Huo; S B Wan; W H Lam; L Li; Z Wang; K R Landis-Piwowar; D Chen; Q P Dou; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

8.  Feature-Based Molecular Network-Guided Dereplication of Natural Bioactive Products from Leaves of Stryphnodendron pulcherrimum (Willd.) Hochr.

Authors:  Paulo Gomes; Luis Quirós-Guerrero; Consuelo Silva; Sônia Pamplona; Jean A Boutin; Marcos Eberlin; Jean-Luc Wolfender; Milton Silva
Journal:  Metabolites       Date:  2021-04-29

9.  Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells.

Authors:  Matthew J Kesic; Steven O Simmons; Rebecca Bauer; Ilona Jaspers
Journal:  Free Radic Biol Med       Date:  2011-04-19       Impact factor: 7.376

10.  Prodrugs of fluoro-substituted benzoates of EGC as tumor cellular proteasome inhibitors and apoptosis inducers.

Authors:  Zhiyong Yu; Xu Long Qin; Yan Yan Gu; Di Chen; Qiuzhi Cindy Cui; Tao Jiang; Sheng Biao Wan; Q Ping Dou
Journal:  Int J Mol Sci       Date:  2008-06-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.